| 缩写名/全名 |
MOL CANCER RES
MOLECULAR CANCER RESEARCH |
||||||||||||||||||||||||
| ISSN号 | 1541-7786 | ||||||||||||||||||||||||
| 研究方向 | 医学-细胞生物学 | ||||||||||||||||||||||||
| 影响因子 | 2015:4.51, 2016:4.974, 2017:4.597, 2018:4.484, 2019:4.63, | ||||||||||||||||||||||||
| 出版国家 | UNITED STATES | ||||||||||||||||||||||||
| 出版周期 | Monthly | ||||||||||||||||||||||||
| 年文章数 | 208 | ||||||||||||||||||||||||
| 出版年份 | 2002 | ||||||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||||||
| 审稿周期(仅供参考) | 偏慢,4-8周 |
||||||||||||||||||||||||
| 录用比例 | 较易 | ||||||||||||||||||||||||
| 投稿链接 | http://mcr.msubmit.net/cgi-bin/main.plex | ||||||||||||||||||||||||
| 投稿官网 | http://mcr.aacrjournals.org/ | ||||||||||||||||||||||||
| h-index | 124 | ||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1541-7786%5BISSN%5D | ||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | HDAC Inhibition for the Treatment of Epithelioid Sarcoma: Novel Cross Talk Between Epigenetic Components. Author: Lopez G, Song Y, Lam R, Ruder D, Creighton CJ, Bid HK, Bill KL, Bolshakov S, Zhang X, Lev D, Pollock RE. Journal: Mol Cancer Res. 2016 Jan;14(1):35-43. doi: 10.1158/1541-7786.MCR-15-0295. Epub 2015 Sep 22. PubMed |
| 2. | Integrative Analysis Reveals the Transcriptional Collaboration between EZH2 and E2F1 in the Regulation of Cancer-Related Gene Expression. Author: Xu H, Xu K, He HH, Zang C, Chen CH, Chen Y, Qin Q, Wang S, Wang C, Hu S, Li F, Long H, Brown M, Liu XS. Journal: Mol Cancer Res. 2016 Feb;14(2):163-72. doi: 10.1158/1541-7786.MCR-15-0313. Epub 2015 Dec 9. PubMed |
| 3. | The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma. Author: Li W, Cohen A, Sun Y, Squires J, Braas D, Graeber TG, Du L, Li G, Li Z, Xu X, Chen X, Huang J. Journal: Mol Cancer Res. 2016 Apr;14(4):344-53. doi: 10.1158/1541-7786.MCR-15-0466. Epub 2016 Feb 1. PubMed |
| 4. | Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma. Author: Zhou X, Guo J, Ji Y, Pan G, Liu T, Zhu H, Zhao J. Journal: Mol Cancer Res. 2016 May;14(5):448-57. doi: 10.1158/1541-7786.MCR-15-0480. Epub 2016 Feb 19. PubMed |
| 5. | Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma. Author: Lin N, Di C, Bortoff K, Fu J, Truszkowski P, Killela P, Duncan C, McLendon R, Bigner D, Gregory S, Adamson DC. Journal: Mol Cancer Res. 2012 Feb;10(2):208-17. doi: 10.1158/1541-7786.MCR-10-0109. Epub 2012 Jan 12. PubMed |
| 6. | Migfilin regulates esophageal cancer cell motility through promoting GSK-3β-mediated degradation of β-catenin. Author: He H, Ding F, Li Y, Luo A, Chen H, Wu C, Liu Z. Journal: Mol Cancer Res. 2012 Mar;10(3):273-81. doi: 10.1158/1541-7786.MCR-11-0419. Epub 2012 Jan 13. PubMed |
| 7. | SPINDLIN1 promotes cancer cell proliferation through activation of WNT/TCF-4 signaling. Author: Wang JX, Zeng Q, Chen L, Du JC, Yan XL, Yuan HF, Zhai C, Zhou JN, Jia YL, Yue W, Pei XT. Journal: Mol Cancer Res. 2012 Mar;10(3):326-35. doi: 10.1158/1541-7786.MCR-11-0440. Epub 2012 Jan 18. PubMed |
| 8. | Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells. Author: Zhang Y, Gong W, Dai S, Huang G, Shen X, Gao M, Xu Z, Zeng Y, He F. Journal: Mol Cancer Res. 2012 Apr;10(4):516-22. doi: 10.1158/1541-7786.MCR-11-0473. Epub 2012 Mar 23. PubMed |
| 9. | Biological functions of cytokeratin 18 in cancer. Author: Weng YR, Cui Y, Fang JY. Journal: Mol Cancer Res. 2012 Apr;10(4):485-93. doi: 10.1158/1541-7786.MCR-11-0222. Epub 2012 Mar 27. PubMed |
| 10. | Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells. Author: Wang X, Lu N, Niu B, Chen X, Xie J, Cheng N. Journal: Mol Cancer Res. 2012 May;10(5):588-96. doi: 10.1158/1541-7786.MCR-11-0416. Epub 2012 Apr 20. PubMed |
|
|
